Trial Profile
Valsartan on top of standard therapy as a novel therapeutic strategy to treat cardiac dysfunction in patients with infammatory cardiomyopathies
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2024
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- Acronyms NOVEL
- 31 Jan 2024 Status changed from recruiting to completed.
- 13 Jul 2011 New trial record